FDA officials aim to stop misuse of the term ‘digital biomarker’
Regulatory NewsFerdous Al-Faruque
Clinical TrialsDiagnostics/IVDsMedical DevicesNorth AmericaProduct LifecycleRegulatory NewsFerdous Al-FaruqueClinical TrialsDiagnostics/IVDsMedical DevicesNorth AmericaProduct Lifecycle